These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13249394)

  • 21. The clinical significance of keratosis of the larynx as a premalignant lesion.
    PUTNEY FJ; O'KEEFE JJ
    Trans Am Laryngol Assoc; 1953; 74():117-28. PubMed ID: 13136228
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actinic keratosis among seafarers.
    Oldenburg M; Kuechmeister B; Ohnemus U; Baur X; Moll I
    Arch Dermatol Res; 2013 Nov; 305(9):787-96. PubMed ID: 23818098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study.
    Boone MA; Norrenberg S; Jemec GB; Del Marmol V
    Exp Dermatol; 2013 Feb; 22(2):93-7. PubMed ID: 23301958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis.
    Wolf JE; Rigel DS
    Int J Dermatol; 2013 Sep; 52(9):1063-70. PubMed ID: 23962263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation between clinical and histological clearance of actinic keratoses.
    Rivers JK
    Br J Dermatol; 2017 Jan; 176(1):8-9. PubMed ID: 28098368
    [No Abstract]   [Full Text] [Related]  

  • 28. [Darier's disease with localization on the scalp].
    DUPERRAT B; GOLE L; MASCARO JM
    Bull Soc Fr Dermatol Syphiligr; 1960; 67():232-4. PubMed ID: 13725095
    [No Abstract]   [Full Text] [Related]  

  • 29. [The existence of the parakeratotic form of cornification from the histochemical point of view].
    BRAUN-FALCO O
    Klin Wochenschr; 1957 Dec; 35(23):1182-4. PubMed ID: 13515163
    [No Abstract]   [Full Text] [Related]  

  • 30. The current options in the management of actinic keratosis.
    Larkö O
    G Ital Dermatol Venereol; 2009 Aug; 144(4):445-52. PubMed ID: 19755948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit.
    Hagele TJ; Levender MM; Davis SA; Williford PM; Feldman SR
    J Cutan Med Surg; 2012; 16(2):107-14. PubMed ID: 22513063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index.
    Dirschka T; Pellacani G; Micali G; Malvehy J; Stratigos AJ; Casari A; Schmitz L; Gupta G;
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1295-1302. PubMed ID: 28401585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
    Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
    Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation and validation of the Spanish version of the Actinic Keratosis Quality of Life questionnaire.
    Longo Imedio I; Serra-Guillén C
    Actas Dermosifiliogr; 2016; 107(6):474-81. PubMed ID: 27083391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumican as a novel marker for differential diagnosis of Bowen disease and actinic keratosis.
    Takayama R; Ishiwata T; Ansai S; Yamamoto T; Matsuda Y; Naito Z; Kawana S
    Am J Dermatopathol; 2013 Dec; 35(8):827-32. PubMed ID: 23719483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histochemistry of hyperkeratosis].
    SPIER HW; VAN CANEGHEM P
    Arch Klin Exp Dermatol; 1957; 206():344-63. PubMed ID: 13522057
    [No Abstract]   [Full Text] [Related]  

  • 37. Case-based experience in the use of 5-fluorouracil cream 0.5% as monotherapy and in conjunction with glycolic acid peels for the treatment of actinic keratosis.
    Goldberg DJ
    J Cosmet Laser Ther; 2010 Feb; 12(1):42-6. PubMed ID: 20085453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case to be diagnosed].
    PIERARD J; VAN DE PUTTE J
    Arch Belg Dermatol Syphiligr; 1956 Sep; 12(2):240-2. PubMed ID: 13382348
    [No Abstract]   [Full Text] [Related]  

  • 39. [Several cases of Mibelli's porokeratosis].
    CORDERO A
    Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr; 1955; (2):146-7. PubMed ID: 13341792
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of Mibelli's porokeratosis].
    YEMNI O
    Tip Fak Mecm; 1954; 17(2):208-13. PubMed ID: 13205589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.